Clinical trial
Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following…
NCT00463723 · University Hospital Freiburg, Other · Terminated
Key facts
| NCT number | NCT00463723 |
|---|---|
| Title | Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following Penetrating Keratoplasty |
| Lead sponsor | University Hospital Freiburg, Other |
| Collaborators | Sucampo Pharmaceuticals, Inc. Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Penetrating Keratoplasty |
| Intervention type | Drug |
| Interventions | FK506 0.06% (eye drops) |
| First posted | Apr 20, 2007 |
| Last update posted | Apr 20, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: